Alopecia Areata

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2026-07-10
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026
PRAC meeting highlights include new safety information for desogestrel- and etonogestrel-containing contraceptives and for Litfulo (ruxoliti…